Search - tctmd.com

Displaying 561 - 580 of 2472

Sort: Relevancy | Date

News Daily News

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

Shelley Wood

January 20, 2016

News Daily News

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

Michael O'Riordan

January 18, 2016

News Daily News

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

Michael O'Riordan

January 18, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

News Industry News

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

January 14, 2016

News Industry News

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

January 06, 2016

News Daily News

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Michael O'Riordan

December 27, 2015

News Daily News

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Michael O'Riordan

December 27, 2015

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

Presentation

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Presenter: William Wilson

December 22, 2015

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

德国数据显示 TAVR 的出现对临床实践模式产生影响

L.A. McKeown

December 16, 2015

News Daily News

German Data Show Impact of TAVR Introduction on Clinical Practice Patterns

L.A. McKeown

December 16, 2015

News Daily News

Datos Alemanes Confirman el Impacto de la Introducción de la TAVR en los Patrones de Práctica Clínica

L.A. McKeown

December 16, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Daily News

Senate Votes to Repeal Medical Device Tax, Though Presidential Veto Likely

Yael L. Maxwell

December 08, 2015

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

Advertisement

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

FDA Grants Go-Ahead for Low-Risk TAVR Study

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Transcatheter Pulmonary Valve Replacement With Edwards Sapien: Toronto Experience

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

德国数据显示 TAVR 的出现对临床实践模式产生影响

German Data Show Impact of TAVR Introduction on Clinical Practice Patterns

Datos Alemanes Confirman el Impacto de la Introducción de la TAVR en los Patrones de Práctica Clínica

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

Senate Votes to Repeal Medical Device Tax, Though Presidential Veto Likely

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content